CV-Cagatay Taskiran

Name: Cagatay Taskiran

Birth date: 01.01.1974

Birth place: Anamur

Nationality: T.C.

Education:

Institute

Years

Medical Faculty Hacettepe University, Faculty of Medicine June 1997 Residency Hacettepe University, Faculty of Medicine, Department

of OB/GYN March 2002

Assoc.Prof. OB/GYN December 2007

Subspeciality Gynecologic oncological surgery June 2011

Institutes:

Institute

Years

Resident Hacettepe University, Faculty of Medicine, Department of OB/GYN

October 1997-March 2002

Specialist Hacettepe University, Faculty of Medicine, Department of OB/GYN

March 2002-October 2002

Assist. Prof. Hacettepe University, Faculty of Medicine, Department of OB/GYN

October 2002-June 2003

Assist. Prof. Gazi University, Faculty of Medicine, Department of OB/GYN

June2003-2007

Assoc.Prof. Gazi University, Faculty of Medicine, Department of OB/GYN

2007-2011

Assoc.Prof. VKV American Hospital 2011-2013 Professor VKV Koc University and American Hospital 2013-

Scientific Society Memeberships: European Society of Gynecologic Oncology.

International Gynecologic Cancer Society

Society of Gynecologic Oncology

Türk Jinekolojik Onkoloji Derneği

Minimal İnvaziv Jinekolojik Onkoloji Derneği

Minimal İnvaziv Jinekoloji Derneği

Scientific Society Membership of Executive Board

European Society of Gynecologic Oncology.

Minimal İnvaziv Jinekolojik Onkoloji Derneği

Minimal İnvaziv Jinekoloji Derneği

PUBLICATIONS

A. International Journals

A1. C. Taskiran, Erdem, O., Onan, A., Arisoy, O., Acar, A., Vural, C., Erdem, M., Ataoglu, O. ve Guner, H., “The prognostic value of endoglin (CD105) expression in ovarian carcinoma,” Int. J. Gynecol. Cancer, 16, 1789-93 (2006). A2. Onan, MA., C. Taskiran, Bozdayi, G., Biri, A., Erdem, O., Acar, A., Gunaydin, G., Rota, S., Ataoglu, O., ve Guner, H., “Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population,” Eu.r J. Gynaecol. Oncol., 26, 632-5 (2005). A3. C. Taskiran, Aktas, D., Yigit-Celik, N., Alikasifoglu, M., Yuce, K., Tuncbilek, E. ve Ayhan, A., “CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer,” Gynecol. Oncol., 101, 503-6 (2006). A4. C. Taskiran, Baltaci, V. ve Gunalp, S., “A rare spermatogenic disorder, globozoospermia: is there a role for Y chromosome microdeletions?,” J. Reprod. Med., 51, 628-634 (2006). A5. C. Taskiran, Erdem, O., Onan, A., Bozkurt, N., Yaman-Tunc, S., Ataoglu, O. ve Guner, H., “The role of frozen section evaluation in the diagnosis of adnexal mass,” Int. J. Gynecol. Cancer, 18, 235-40 (2008).

A6. Erdem, O., C. Taskiran, Onan, M.A., Erdem, M., Guner, H. ve Ataoglu, O., “CD105 expression is an independent predictor of survival in patients with endometrial cancer,” Gynecol. Oncol., 103, 1007-11 (2006). A7. Ayhan, A., Bozdag, G., C. Taskiran, Gultekin, M., Yuce, K. ve Kucukali, T., “The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma,” Gynecol. Oncol., 103, 902-5 (2006). A8. Onan, M.A., Turp, A.B., C. Taskiran, Ozogul, C. ve Himmetoglu, O., “Spontaneous closure of the hymen during pregnancy,” Am. J. Obstet. Gynecol., 193, 889-91 (2005). A9. Taner, M.Z., C. Taskiran, Onan, M.A., Gursoy, R. ve Himmetoglu, O., “Therapeutic value of trichloroacetic acid in the treatment of isolated genital warts of the external genitalia”. Journal of Reprod Med, 52, 521-5 (2007). A10. Taner, M.Z., C. Taskiran, Onan, M.A., Uluturk, A. ve Himmetoglu, O., “Genital human papillomavirus infection in the male sexual partners of women with isolated vulvar lesions,” Int. J. Gynecol. Cancer, 16, 791-4 (2006). A11. C. Taskiran, Yuce, K., Ozdemir-Geyik, P., Kucukali, T. ve Ayhan, A., “Predictability of retroperitoneal lymph node metastasis by using clinico-pathological variables in surgically staged endometrial cancer,” Int. J. Gynecol. Cancer, 16, 1342-7 (2006). (tezden üretilmiştir) A12. Ayhan, A., Gultekin, M., C. Taskiran, Dursun, P., Firat, P., Bozdag, G., Yigit-Celik, N. ve Yuce, K., “Ascites and epithelial ovarian cancers: a reapraisal with respect to different aspects,” Int. J. Gynecol. Cancer, 17, 68-75 (2007). A13. Ayhan, A., Gultekin, M., Yigit-Celik, N., Dursun, P., C. Taskiran, Aksan, G. ve Yuce, K., “Occult metastasis in early ovarian cancers: risk factors and associated prognosis,” Am. J. Obstet. Gynecol., 196, 81.e1-81.e6 (2007). A14. Ayhan, A., C. Taskiran, Yigit-Celik, N., Gultekin, M., Tuncer, S., Guler, N. ve Yuce, K., “Topotecan as a second-line therapy in patients with ovarian and primary peritoneal cancer: initial response and long-term follow-up,” Eur. J. Gynaecol. Oncol., 27, 603-6 (2006). A15. Onan, M.A., Turp, A.B., Saltik, A, Akyurek, N., C. Taskiran ve Himmetoglu, O., “Primary omental pregnancy: case report,” Hum. Reprod., 20, 807-9 (2005). A16. Taner, M.Z., Ozpolat, E., C. Taskiran, Onan, M.A., Gursel, T., Karabulut, E., Gursoy, R. ve Himmetoglu, O., “Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study,” Maturitas, 53, 267-73 (2006). A17. Ayhan, A., C. Taskiran, Yigit-Celik, N., Bozdag, G., Gultekin, M., Usubutun, A., Guler, N. ve Yuce, K., “Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?,” Int. J. Gynecol. Cancer, 16, 484-9 (2006).

A18. Ayhan, A., C. Taskiran, Simsek, S. ve Sever, A., “Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?,” Int. J. Gynecol. Cancer, 16, 805-8 (2006). A19. Ayhan, A., Gultekin, M., C. Taskiran, Aksan, G., Celik, N.Y., Dursun, P., Salman, M.C., Yuce, K. ve Kucukali, T., “The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience,” Am. J. Obstet. Gynecol., 194, 49-56 (2006). A20. Ayhan, A., C. Taskiran, Celik, C. ve Yuce, K., “The long-term survival of women with surgical stage II endometrioid type endometrial cancer,” Gynecol. Oncol., 93, 9-13 (2004). A21. Dursun, P., Salman, M.C., C. Taskiran, Yuce, K. ve Ayhan, A., “Retroperitoneal leiomyomatosis: a case report,” Int. J. Gynecol. Cancer, 15, 1222-5 (2005). A22. Ayhan, A., C. Taskiran, Bozdag, G., Altinbas, S., Altinbas, A. ve Yuce, K., “Endodermal sinus tumor of the ovary: the Hacettepe University experience,” Eur. J. Obstet. Gynecol. Reprod. Biol., 123, 230-4 (2005). A23. Ayhan, A., Gultekin, M., C. Taskiran, Celik, N.Y., Usubutun, A., Kucukali, T. ve Yuce, K., “Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables,” Gynecol. Oncol., 97, 400-4 (2005). A24. Ayhan, A., Gultekin, M., C. Taskiran, Salman, M.C., Celik, N.Y., Yuce, K., Usubutun, A. ve Kucukali, T., “Routine appendectomy in epithelial ovarian carcinoma: is it necessary?” Obstet. Gynecol., 105, 719-24 (2005). A25. Dursun, P., Salman, M.C., C. Taskiran, Usubutun, A. ve Ayhan, A., “Primary neuroendocrine carcinoma of the fallopian tube: a case report,” Am. J. Obstet. Gynecol., 190, 568-71 (2004). A26. Ozcakar, L., Kara, M., Erol, M., Kaymak, B., Akinci, A., C. Taskiran ve Ayhan, A., “A reappraisal on the management of lumbosacral plexopathies in gynecological malignancies: where do the physiatrists stand?” Int. J. Gynecol. Cancer, 15, 915-7 (2005). A27. Ayhan, A., C. Taskiran, Celik, C., Guney, I., Yuce, K., Ozyar, E., Atahan, L. ve Kucukalı, T., “Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?,” Gynecol. Oncol., 86, 259-263 (2002). A28. Ayhan, A., C. Taskiran, Celik, C., Yuce, K. ve Kucukali, T., “The influence of cytoreductive surgery on survival and morbidity in Stage IVB endometrial cancer,” Int. J. Gynec. Cancer, 2, 448-53 (2002). A29. Ayhan, A., C. Taskiran, Celik, C., Yuce, K. ve Aksu, T., “Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns,” Eur. J. Gynaecol. Oncol., 23, 553-6 (2002). A30. Ayhan, A., C. Taskiran, Yuce, K. ve Kucukali, T., “The prognostic value of nuclear and the revised International Federation of Gynecology and Obstetrics grading of endometrial adenocarcinoma,” Int. J. Gynecol. Pathol., 22, 71-4 (2003).

A31. Ayhan, A., Celik, H., C. Taskiran, Bozdag, G. ve Aksu, T., “Oncologic and therapeutic outcome after fertility-saving surgery in ovarian cancer,” Eur. J. Gynaecol. Oncol., 24, 223-32 (2003). A32. Ayhan, A., Guney, I., Saygan-Karamursel, B. ve C. Taskiran., “Ovarian metastasis of primary biliary and gallbladder carcinomas,” Eur. J. Gynaecol. Oncol., 22, 377-8 (2001). A33. Baykal, C., Baykal, Y., C. Taskiran, Esinler, I., Demirol, A., Doğan, R. ve Ayhan, A., “An extraordinary case of four primary tumors in the same patient, involving uterine cervix, lung, skin, and rectum,” Eur. J. Gynaecol. Oncol., 23, 451-2 (2002). A34.Atalay, F., C. Taskiran, Taner, M.Z., Pak, I., Or, M., Tuncer, S. “Detection of human Papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma.” J. Obstet. Gynaecol. Res. 33, 823-8 (2007). A35.Turkyilmaz, E., Korucuoglu, U., Kutlusoy, F., Efeturk, T., Dogan, H.T., Onan, A., Guner, H., C. Taskiran. “Recurrent mucinous cystadenoma: a laparoscopic approach.” Arch. Gynecol. Obstet., 279, 387-9 (2009).

A36. Dinc B, Rota S, Onan A, Bozdayı G, Taskiran C, Biri A, Güner H. Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies Braz J Infect Dis Jan-Feb 14(1): 19-23, 2010.

A37. Onan A, Özkan S, Korucuoglu Ü, Aksakal N, Taşkıran Ç, Aygün R, Güner H, Knowledge on and Attitude Toward Human Papillomavirus Infection and its Vaccine in a Turkish Subpopulation. Türkiye Klinikleri Journal of Medicine 29(3), 594-598, 2009.

A38. Onan MA, Taskıran Ç, Karabacak O, Açar A, Korucuoglu Ü, Tıras MB, Retrospective Analysis of Laparoscopically Treated Cases of Tubo-Ovarian Abscess, Turkiye Klinikleri Journal of Medicine, 29(4), 872-6, 2009.

A39. Turkish Cervical Cancer and Cervical Cytology Research Group,Prevalance of Cervical cytological abnormalities in Turkey,International Journal of Gynaecology and Obstetrics 2009, 106(3), 206-209.

A40. Esinler, I., Guven, S., Akyol, D., Guvendag Guven, E.S., C. Taskiran ve Ayhan, A., “Abdominal wall endometriosis without previous surgery,” J. Obstet. Gynaecol., 24, 931 (2004). A41.Yildirim, M., Bozkurt, N., Kurdoglu, M., C. Taskiran, Oktem, M., Dilek, K.U. “Histopathologic findings in women with postmenopausal bleeding: implication for endometrial thickness and circulating levels of sex steroid hormones.” Arch. Gynecol. Obstet. 276, 305-10 (2007). A42.Taner, M.Z., Kurdoglu, M., C. Taskiran, Onan, M.A., Gunaydin, G., ve Himmetoglu, O. “Prenatal diagnosis of achondrogenesis type I: a case report” Cases J., 18, 406 (2008). A43. Urman B, Boza A, Ata B, Aksu S, Arslan T, Taskiran C. Intraoperative endoscopic ultrasound guidance for laparoscopic excision of invisible symptomatic deep intramural

myomas. J Obstet Gynaecol. 2018 Jan;38(1):85-89. doi: 10.1080/01443615.2017.1327515. Epub 2017 Aug 1. A44. Isci Bostanci E, Guler I, Erdem O, Taskiran C, Onan MA. A rare case of ovarian cancer in a pregnant woman with metastatic non-small cell lung cancer.J Obstet Gynaecol. 2017 Sep 14:1-2. doi: 10.1080/01443615.2017.1343292. [Epub ahead of print] No abstract available. A45. Urman B, Arslan T, Aksu S, Taskiran C. Laparoscopic Repair of Cesarean Scar Defect "Isthmocele".J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):857-8. doi: 10.1016/j.jmig.2016.03.012. Epub 2016 Mar 19. A46. Urman B, Ata B, Arslan T, Aksu S, Taskiran C. Parasitic Myomas and an Adenomyoma Obstructing the Ureter After Power Morcellation of Myomas and Endometriotic Nodule Resection.J Obstet Gynaecol Can. 2016 Apr;38(4):362-5. doi: 10.1016/j.jogc.2016.02.011. Epub 2016 Apr 23. A47. Yuksel A, Bildik G, Senbabaoglu F, Akin N, Arvas M, Unal F, Kilic Y, Karanfil I, Eryılmaz B, Yilmaz P, Ozkanbaş C, Aksoy S, Guzel Y, Balaban B, Ince U, Iwase A, Urman B, Oktem O.The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.Hum Reprod. 2015 Dec;30(12):2926-35. doi: 10.1093/humrep/dev256. Epub 2015 Oct 13. A48. Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B, Mandel NM, Esen T, Iwase A, Urman B, Oktem O.GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.Hum Reprod. 2015 Dec;30(12):2912-25. doi: 10.1093/humrep/dev257. Epub 2015 Oct 13. A49. du Bois A, Reuss A, Pujade-Lauraine E, Pignata S, Ledermann J, Casado A, Sehouli J, Mirza M, Colombo N, Marth C, Witteveen E, Del Campo J, Calvert P, Aravantinos G, Vardar MA, van der Zee AG, Korach J, Taskiran C, Fehr M, Glasspool R, Pfisterer J, Cibula D, Vergote I; member trial groups of the European Network of Gynaecological Oncological Trial Groups (ENGOT).European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.Int J Gynecol Cancer. 2015 Sep;25(7):1328-30. doi: 10.1097/IGC.0000000000000478. A50. Marth C, du Bois A, Schauer C, du Bois A, Casado A, Vergote I, del Campo JM, Goudopoulou A, Pujade-Lauraine E, Bruchim I, Colombo N, Pignata S, Ledermann J, Chekerov R, Raza Mirza M, Westermann A, Glasspool R, Taskiran C, Fehr M, Cibula D.The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership.Int J Gynecol Cancer. 2015 Jul;25(6):1094-5. doi: 10.1097/IGC.0000000000000446. No abstract available. A51. Guler I, Onan AM, Hatipoglu O, Taskiran C, Uner A, Guner H.Carcinoma of the fallopian tube presenting as an axillary palpable mass. J Obstet Gynaecol. 2014 Nov;34(8):749. doi: 10.3109/01443615.2014.923388. Epub 2014 Jun 9. No abstract available.

B. Abstracts Presented at International Meetings B1. Taskiran, C., A.Onan, O. Arisoy, F. Kutlusoy, A. Acar, B. Tiras, H. Guner, ve O. Karabacak. “Laparoscopic management of adnexal masses”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B2. Taskiran, C., O. Erdem, A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O. Ataoglu, H. Guner. “The prognostic value of endoglın (cd105) expressıon ın epıthelıal ovarıan cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B3. Taskiran, C., A. Onan, O. Erdem, F. Kandemir, F. Kutlusoy, O. Ataoglu, H. Guner. “Distribution of cervical preinvasive diseases in Turkısh population after Bethesda III at tertiary referral center”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B4. Taskiran, C., A. Onan, S. Yaman-Tunc, O. Erdem, O. Ataoglu, H. Guner. “The predictive value of frozen section diagnosis in ovarian masses treated by laparotomy”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B5. Taskiran, C., O. Erdem, A. Onan, O. Ataoglu, H. Guner. “What is the importance of immunohistochemically determined lymphovascular space involvement in epithelial ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B6. Taskiran, C., A. Onan, H. Guner. “Early postoperative oral intake after surgery for gynecological cancer including systematic lymphadenectomy”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B7. Taskiran, C., N. Karabacak, A. Onan, E. Demir, O. Arisoy, T. Atasever, H. Guner. “The value of pet-ct in the follow-up of patients with ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B8. Taskiran, C., O. Erdem, A. Onan, O. Ataoglu, H. Guner. “The accuracy of intraoperative assessment of peritoneal washing cytology”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B9. Taskiran, C., A. Onan, P. Ozcan, H. Guner. “Toxicity of docetaxel plus carboplatin combination chemotherapy in the first-line treatment of ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B10. A. Onan, Taskiran, C., G. Gunaydin, E. Demir, A. Bedirli, H. Guner. “Colonic surgery in patients with ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006.

B11. A.Onan, Taskiran, C., O. Arisoy, A. Acar, O. Erdem, O. Ataoglu, H. Guner. “What is the final pathology of patients who have endometrial hyperplasia at D&C and subjected to the hysterectomy”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B12. H. Guner, O. Erdem, Taskiran, C., A. Onan, O. Arisoy, A. Acar, C. Vural, M. Erdem, O. Ataoglu. “The role of angiogenesis determined by CD31 in epıthelial ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B13. H. Guner, O. Erdem, Taskiran, C., A. Onan, O. Ataoglu. “The role of lymphovascular space involvement assessed by hematoxilen&eosin in patients with epithelial ovarian cancer”. 11th Biennial International Gynecologic Cancer Society Meeting (IGCS), October 14-18, Santa Monica, USA, 2006. B14. A. Erdem, Taskiran C., E. Biberoglu, K. Biberoglu. The effect of hormone replacement therapy on serum copper levels. 7th European Congress on Menopause, 3-7 June, 2006. B15. A. Erdem, Taskiran C., E. Biberoglu, K. Biberoglu. The effect of hormone replacement therapy on homocysteine levels. 7th European Congress on Menopause, 3-7 June, 2006. B16. M. Gultekin, P. Dursun, T. Guler, S. Esin, N.Y. Calik, Taskiran, C., K. Yuce, A. Ayhan. “Pre-operative Ca-125 levels: correlation with clinico-pathologic factors”. ESGO 14, İstanbul, Türkiye, 2005. B17. G. Bozdag, Taskiran C., M. Gultekin, P. Dursun, K. Yuce, A. Ayhan. “The predictive value of preoperative Ca 125 level for lymph node metastasis and clinicopathologic features among endometrium cancer patients”. ESGO 14, İstanbul, Türkiye, 2005. B18. G. Bozdag, Taskiran C., M. Gultekin, P. Dursun, K. Yuce, A. Ayhan. “The preoperative platelet count is higher in endometrium cancer patients with the advanced stage and high grade”. ESGO 14, İstanbul, Türkiye, 2005. B19. Taskiran, C., A. Onan, A. Acar, B. Ciftci, H. Guner ve O. Karabacak, “What is The Percentage of Malignancies In Patients Treated with Laparoscopy For Benign Adnexial Mass?” 10th Biennial International Gynecologic Cancer Society Meeting (IGCS), Edinburg, İskoçya, 2004. B20. O. Erdem, Taskiran, C., A. Onan, H. Guner, M. Erdem ve O. Ataoglu, “The Prognostic Role of Angiogenetic Factors In Endometrial Cancer,” 10th Biennial International Gynecologic Cancer Society Meeting (IGCS), Edinburg, İskoçya, 2004. B21. M.A. Onan, Taskiran, C., A. Bedirli, G. Gunaydin, B. Mentes ve H. Guner, “Necessity of Gastrointestinal Surgical Procedures(GSP) In Ovarian Cancer Debulking,” 10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004. B22. M.A. Onan, Taskiran, C., G. Bozdayi, O. Erdem, S. Rota ve H. Guner, “Assessment of Human Papilloma Viral Load By Real-Time Polymerase Chain Reaction (RT-PCR) In Cervical Intraepithelial Neoplasia,” 10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004.

B23. N.Y. Celik, M. Gultekin, Taskiran, C., P. Dursun, M.C. Salman, S. Esin, G. Aksan, A. Usubutun, T. Kucukali, K. Yuce ve A. Ayhan, “Recurrences following a negative SLL in patient with epithelial ovarian carcinoma,” 10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004. B24. P. Dursun, M. Gultekin, N.Y. Celik, Taskiran, C., A. Parlakgumus, G. Aksan, S. Esin ve A. Usubutun, “Comparison of clinico-pathologic and survival characteristics of epithelial ovarian carcinoma with respect to age,” 10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004. B25. M. Gultekin, N.Y. Celik, Taskiran, C., P.Dursun, S. Esin, G. Aksan, G. Bozdag, A. Usubutun, T. Kucukali, K. Yuce ve A. Ayhan, “Upstaging in epithelial ovarian carcinoma,” 10th Biennial International Gynecologic Cancer Society Meeting(IGCS), Edinburg, İskoçya, 2004. B26. Taskiran, C., K. Yuce ve A. Ayhan, “Predictibility of retroperitoneal lymph node metastasis in endometrial cancer,” ESGO 13, Brüksel, Belçika, 2003 (Sözlü sunum). B27. Taskiran, C., K. Yuce ve A. Ayhan, “The role of surgical staging for high risk stage I and stage II endometrial cancer without adjuvant radiotherapy,” ESGO 13, Brüksel, Belçika, 2003 (Sözlü sunum). B28. Taskiran, C., S. Simsek, A. Sever, Z. Yıldırım ve A. Ayhan, “Immediate hormone replacement therapy in endometrial cancer survivors,” ESGO 13, Brüksel, Belçika, 2003 (Sözlü sunum). B29. Taskiran, C., N. Yigit, S. Tuncer, K. Yuce ve A. Ayhan, “Topotecan in the second-line and third-line treatment of ovarian cancer,” ESGO 13, Brüksel, Belçika., 2003. B30. I. Esinler, S. Kumru,Taskiran, C., K. Yuce ve A. Ayhan, “Cervical intraepithelial neoplasia: Hacettepe experience,” ESGO 13, Brüksel, Belçika., 2003. B31. Taskiran, C., N. Yigit, K. Yuce ve A. Ayhan, “Primary peritoneal serous papillary carcinoma: Hacettepe experience,” ESGO 13, Brüksel, Belçika., 2003. B32. Taskiran, C., S. Guvendag, FC, K. Yuce ve A. Ayhan, “Borderline epithelial ovarian neoplasia: Hacettepe experience,” ESGO 13, Brüksel, Belçika, 2003. B33. G. Bozdag, A. Basaran, A. Kızılkılıç, Taskiran, C., K. Yuce ve A. Ayhan, “Fertility-saving surgery for malignant and borderline ovarian tumors,” ESGO 13, Brüksel, Belçika., 2003. B34. G. Bozdag, Taskiran, C., H. Yarali ve A. Ayhan, “Pregnancy after intracytoplasmic sperm injection in a patient with stage I endometrial carcinoma treated with fertility-saving surgery and progestins,” ESGO 13, Brüksel, Belçika, 2003. B35. G. Mocan, P. Fırat, B. Can, Taskiran, C., ve S. Tuncer, “ASCUS and AGUS-Close follow up is necessary,” 28th European Congress of Cytology, Antwerp, Belçika, 2002.

B36. Taskiran, C., A. Altınbas, S. Kiziltas, A. Ayhan ve K. Yuce, “Endodermal sinus tumor of the ovary: The Hacettepe Experience,” 9th Biennial meeting of IGCS (International Gynecologic Cancer Society), Seul, Kore, 2002 (Sözlü sunum). B37. Taskiran, C., B. Peynircioglu, D. Akata, M. Ozmen, O. Akhan ve A. Ayhan, “Comparison of US, CT, and MRI in the prospective evaluation of peritoneal carcinomatosis,” 9th Biennial meeting of IGCS, Seul, Kore, 2002. B38. Taskiran, C., S. Guvendag, S. Guven, H. Yuksel, K. Yuce ve Ali Ayhan, “Vulvar dystrophy: an evaluation of 795 cases,” 9th Biennial meeting of IGCS, Seul, Kore, 2002. B39. A. Ayhan, Taskiran, C., K. Yuce ve T. Kuçukali, “The prognostic value of nuclear grade in endometrial cancer,” ESGO 12 (The European Society of Gynecologic Oncology), Venedik, İtalya, 2001 (Oral presentation). B40. Taskiran, C., M. Basaran, K. Yuce, Z.S. Tuncer ve A. Ayhan, “Prognostic factors predicting retroperitoneal lymph node metastasis in endometrial carcinoma,” ESGO 12 (The European Society of Gynecologic Oncology), Venedik, İtalya, 2001 (Oral presentation) . B41. Taskiran, C., C. Celik, K. Yuce ve A. Ayhan, “Optimal cytoreductive surgery is an independent prognostic indicator in stage IV endometrial cancer,” ESGO, Venedik, İtalya, 2001. B42. A. Ayhan, Taskiran, C., I. Guney, S. Tuncer, C. Celik, L. Atahan, E. Ozyar, K. Yuce ve T. Kuçukali, “Prognostic factors in surgical stage I endometrial cancer,” 8th biennial meeting of IGCS, Buenos Aires, Arjantin, 2000. B43. A. Ayhan, Taskiran, C., I. Guney, C. Celik, K. Yuce, E. Karabulut ve T. Kucukali, “Radical hysterectomy without radiotherapy in surgical stage II endometrial cancer,” 8th biennial meeting of IGCS, Buenos Aires, Arjantin, 2000. B44. Taskiran, C., I. Guney., C. Celik, K. Yuce, T. Kuçukali ve A. Ayhan, “Surgical stage III and IV endometrial cancer: a study of 75 cases,” 8th biennial meeting of IGCS, Buenos Aires, Arjantin, 2000. B45. Taskiran C, Erdem O, Onan A, Bozkurt N, Vural C, Arisoy O, Atraoglu O, Guner H, Maspin expression in endometrial hyperplasia and carcinoma and relation with angiogenesis. 15thInternational Meeting of the ESGO , Jin.Onkoloji , Berlin-Almanya , 2007. B46. Guner H, Erdem O, Korucuoglu U, Onan A, Vural C, Taskiran C. Maspin expression in patients with cervical intraepithelial neoplasia and cervical cancer. 15thInternational Meeting of the ESGO , Jin.Onkoloji , Berlin-Almanya , 2007. B47. Taskiran C, Erdem O, Onan A, Korucuoglu U,Ataoglu O, Guner H. The prognostic importance of lymphovascular space involvement determined by both Hematoxilen & Eosin and immunohistochemical techniques in patients with epithelial ovarian cancer. 15th International Meeting of the ESGO , Jin.Onkoloji , Berlin -Almanya , 2007.

B48. Onan A, Taskiran C, Bedirli A, Turkyılmaz E, Guner H. The value of colon resection in patients with epithelial ovarian cancer. 15th International Meeting of the ESGO , Jin.Onkoloji , Berlin -Almanya , 2007. B49.A. Onan, A. Acar, I. Fidan, C. Taskiran, S. Rota, R. Gursoy, H. Guner. Human papilloma virus positivity in patients with abnormal cervical cytology. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B50.A. Onan, S. Ozkan, U. Korucuoglu, N. Aksakal, C. Taskiran, R. Aygun, H. Guner. Knowledge on and attitude toward human papillomavirus infection and its vaccine in a Turkish subpopulatıon. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B51.B. Dinc, A. Onan, G. Bozdayi, C. Taskiran, S. Rota, H. Guner. Prevalance and genotyping of human papillomavirus (HPV) by in house and real-time pcr in patients with several cervical pathologies. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B52.H. Guner, A. Onan, S. Tunc, I. Fidan, S. Rota, C. Taskiran. The prevalance of human papilloma virus infections in Turkey. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B53.C. Taskiran, A. Onan, A. Bedirli, U. Korucuoglu, E. Turkyilmaz, H. Guner. Partial gastrectomy to achieve optimal cytoreduction in ovarian cancer. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B54.C. Taskiran, A. Onan, E. Turkyilmaz, U. Korucuoglu, A. Bedirli, H. Guner. Diaphragmatic resection by using unipolar cautery for patients wıth ovarian cancer. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B55.H. Guner, C. Taskiran, F. Atalay, U. Korucuoglu, O. Erdem, B. Celtemen, G. Barıt, I. Pak, A. Onan. The survival benefit of lymphatic dissection on survival in patients with endometrial cancer. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. B56.C. Taskiran, F. Atalay, A. Onan, U. Korucuoglu, B. Celtemen, G. Barıt, I. Pak, O. Erdem, H. Guner. What should be the minimum resected lymph node number to detect lymphatic metastasis in endometrial cancer. 12th Biennial Meeting of International Gynecologic Cancer Society 2008. (Oral presentation) B57. Taskıran C, Onan A, Turkyılmaz E, Kerem M, Bedirli A, Guner H.Significant improvement in optimal surgery for epithelial ovarian cancer by ultraradical operations. 16th International Meeting of the European Society of Gynaecological Oncology ESGO , Jinekolojik Onkoloji , Belgrad-Sırbistan , 2009. B58. Onan A, Yaman Tunc S, Taskiran C, Fidan I, Ozkan S, Rota S, Guner H. The prevalance of HPV infection in Turkish population. 16th International Meeting of the European Society of Gynaecological Oncology ESGO , Jinekolojik Onkoloji , Belgrad-Sırbistan , 2009. B59. Guner H, Taskiran C, Onan A, Turkyılmaz E, Kerem M, Erdem O, Bedirli A.Mesocolon lymph node positivity in patients with colon resection for gynecologic malignancy. 16th

International Meeting of the European Society of Gynaecological Oncology ESGO , Jinekolojik Onkoloji , Belgrad-Sırbıstan , 2009. B60. Onan MA, Tunc SY, Korun ZE, Taskiran C, Ozışık MS, Fidan I, Rota S, Guner H. HPV subtypes in patients with cytological abnormalities in Gazi University Outpatient Clinic. 13th Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010, Prague, Czech Republic, 2010. B61. Onan MA, Tunc SY, Ozisik MS, Taskıran C, Korun ZE, Fidan I, Rota S, Gıner H. The prevalance of HPV infection in Gazi University Outpatient Clinic. 13th Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010, Prague, Czech Republic, 2010. B62. Türk Jinekolojik Onkoloji Grubu. HPV prevalance in Turkey: A Multicenter Turkish Gynecologic Oncology Group Study. 13th Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010, Prague, Czech Republic, 2010. B63. Güner H, Cakıcı C, Onan A, Taskiran C, Turkyılmaz E, Buyrukcu BA, Ustun H. Comparison of cervical smear results recieved by doctors and recieved by cervix self-smear test kit. 13th Biennial Meeting of the International Gynecologic Cancer Society-IGCS 2010, Prague, Czech Republic, 2010. B64. Misirlioglu S,1 Turkgeldi E,1 Arvas M,2 Taskiran C.1 Total Laparoscopic Radical Trachelectomy 45th AAGL Global Congress of Minimally Invasive Gynecology Orlando, Florida November 14-18, 2016

B65.S. Misirlioglu 1, C. Taskiran 1, O. Bilge 1, M. Arvas 2 Suprarenal Para-Aortic Lymphadenectomy in Advanced Cervical Cancer 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal October 28-31, 2016 B66. S. Misirlioglu 1, C. Taskiran 1, A. Alper 1, M. Kerem 2 and M. Arvas 3. Liver mobilisation and vascular isolation, diaphragmatic stripping and resection, periportal lymphadenectomy, liver resection 47th Annual Meeting of the Society of Gynecologic Oncology, San Diego, California March 19-22, 2016 B67.S.Misirlioglu1, C.Taskiran1, T.Arslan2, D.Vatansever1, M.Arvas2 Total laparoscopic nerve-sparing radical trachelectomy 49th Annual Meeting of the The Society of Gynecologic Oncology,New Orleans, Los Angeles March 24 – 27, 2018 B68. Taskiran1, S. Misirlioglu1, M. Arvas2, G. Bildik1, N. Akin1, O. Oktem1 ESGO-0421 Translational Research Luteal Phase Ovarian Stimulation Protocol For Gynecological Cancer Patients With Time Constraints C. 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Nice, France; October 24-27, 2015 B69. C Taskiran1, S. Misirlioglu1, M. Arvas2, G. Bildik1, N. Akin1, O. Oktem1 ESGO-0424 Translational Research GNRH Agonist Leuprolide Acetate Neither Activates Anti-Apoptotic Genes

Nor Protects Human Ovary And Granulosa Cells From Dna Damage And Apoptosis Induced By Cyclophosphamide 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Nice, France; October 24-27, 2015 B70. M. Kerem1, S. Yildiz Oguz2, E. Bostanci3, S. Misirlioglu2, F. Karatas3, K. Dikmen1, A. Alper4, M. Arvas5, H. Guner3, A. Onan3, C. Taskiran2 IGCS-0666 Ovarian Cancer The Value Of Liver Resection At Primary, Secondary Or Tertiary Cytoreductive Surgery For Ovarian Cancer 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal October 28-31, 2016 B71. S. Misirlioglu1, C. Taskiran1, A. Onan2, F. Karatas2, S. Yildiz Oguz1, I. Guler2, E. Bostanci2, A. Bedirli3, M. Kerem3, E. Balik4, M. Arvas5, H. Guner2 IGCS-0673 Ovarian Cancer The Role Of Protective Ileostomy And The Validity Of Bowel Resection As A Part Of Cytoreductive Surgery For Advanced Stage Epithelial Ovarian Cancer 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal October 28-31, 2016 B72. C Taskiran1, S. Misirlioglu1, S. Yildiz Oguz1, F. Karatas2, E. Bostanci2, M. Kerem3, E. Balik4, M. Arvas5, H. Guner2 IGCS-0677 Ovarian Cancer Does Scoring Systems Really Predict Resectability Or Should We Define New Algorithm For Advanced Stage Epithelial Ovarian Cancer 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal October 28-31, 2016

B73. C. Taskiran1, S. Misirlioglu1, A. Onan2, S. Yildiz Oguz1, F. Karatas2, E. Bostanci2, M. Kerem3, E. Balik4, A. Alper4, M. Arvas5, H. Guner2 IGCS-0690 Ovarian Cancer How Can Optimal Cytoreduction Rates Increased Over Ninety Percent With A Minimal Usage Of Neoadjuvant Chemotherapy? 16th Biennial Meeting of the International Gynecologic Cancer Society, Lisbon, Portugal October 28-31, 2016

D. Publications at National Journals: D1. Tıraş, M.B., Ç. Taşkıran, Onan, A., Dilek,T.U.K., Biri, A., Bozkurt, N. and Güner H., “The success rate of Burch procedure when it is performed with laparoscopic total hysterectomy,” Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, 111-5, (2005). D2. Tıraş, M.B., Ç. Taşkıran, Onan, A., Odabaşı, A.R., Dilek, U.K. and Güner, H., “Evaluation of 30 cases of total laparoscopic hysterectomy,” Türkiye Klinikleri Jinekoloji Obstetrik Dergisi, 15, 116-122, (2005). D3. Tıraş, B. and Ç. Taşkıran, “treatment options during postmenopausal osteoporosis,” Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, özel sayı 1, 21-31, (2005). D4. Ç. Taşkıran, Başaran, A. ve Günalp G. S., “Globozoospermia: the last point at male infertility,” Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 2, 273-9, (2005).

D5. Salman, M.C., Gültekin, M., Ç. Taşkıran ve Ayhan, A.,. “Hormones and breast,” Türk Jinekolojik Onkoloji Dergisi, 8, 37-53, (2005). D6. Ç. Taşkıran, Açar, A., Yılmaz, E., Onan, A., Tunç, L., Ataoğlu, Ö., Güner, H. Retroperitoneal and intraabdominal malignant fibrous histiocytoma: case report. Türk Jinekolojik Onkoloji Dergisi, 8, 111-114, (2005). D7. Taner, M.Z., Akçin, Ü., Ç. Taşkıran, Onan, A., Önder, M. ve Himmetoğlu, Ö., “Congenital Syphilis as a Cause of Hydrops Fetalis in a Woman With Spyhilis Incognito,” J. Turkish German Gynecol. Assoc., 5, 318-20, (2004). D8. Yılmaz, G., Erdem, Ö., Onan, A., Ç. Taşkıran ve Ataoğlu, Ö., “Sex cord stromal elements within endometrial stromal sarcoma,” Türk jinekolojik onkoloji dergisi, 7, 83-87, (2004). D9. Bozkurt, N., Arısoy, Ö., Ç. Taşkıran, Kutlusoy, F., Kurdoglu, Z., Himmetoğlu Ö. “MPV values of patients with gestational hypertension and preeclampsia”. Türk fertilite dergisi, 14, 209-12, (2006). D10. Bozkurt, N., Korucuoglu, U., Arisoy, Ö., Ç. Taşkıran, Himmetoğlu Ö. “The mean platelet volume in subjects with intrauterine growth retardation”. Türk fertilite dergisi, 14, 213-16, (2006). D11. Güner, H., Ç. Taşkıran. “Epidemiology of cervical cancer and HPV”. Uzmanlık sonrası eğitim ve güncel gelişmeler dergisi, 4, 11-19, (2007). D12. Ç. Taşkıran, Kurdoğlu, M., Bozkurt, N., Polat, M., Kurdoğlu, Z., Yıldırım, M. “The effect of uterine myomas on hematological parameters”. Türk fertilite dergisi, 14, 195-99, (2006). D13. Yılmaz E., Onan A., Ç. Taşkıran, Günaydın G., Güler İ., Korucuoğlu Ü., Güner H. “Vaginal aggressive angiomixoma: case report”. Türk jinekolojik onkoloji dergisi 9, 50-53 (2006). D14. Ç. Taşkıran, Yılmaz E., Onan A., Güner H. “The value of surgical staging in cervical cancer”. Türk jinekolojik onkoloji dergisi 9, 27-34 (2006). D15.Guner H., Yılmaz E., Ç.Taşkıran. The value of neoadjuvant chemotherapy in ovarian cancer. Türkiye Klinikleri J Surg Med Sci, 3, 70-76, (2007). D16.Yılmaz E., Ç. Taşkıran, Tıraş B., Guner H., Karabacak O. Experience of simple hysterectomy at tertiary university clinic. TJOD Dergisi, 5, 195-201, (2008).

Editor or editorial board memebership at national books:

Gynecologic Oncology, Editor: Ali Ayhan Editorial board: Polat Dursun, Murat Gültekin, Çağatay Taşkıran; Güneş Kitabevi, 2013. Chapter in International Book

Cagatay Taskiran, Anıl Onan, Haldun Guner. Role of retroperitoneal lymphatic debulking in gynecologic cancers. Textbook of Gynecological Oncology, ESGO, 2nd Edition. Editors: Ayhan, Reed, Gultekin, Dursun.

Cagatay Taskiran, Selim Misirlioglu, Anıl Onan, Haldun Guner, Ali Ayhan . Sentinel Lymph Node in Cervical Cancer, ESGO Textbook of Gynaecological Oncology (3rd Edition, 2016) Editors: Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun

a-Chapter in National books:

Fa1. Taşkıran, Ç., “Uterine Sarcomas”. Kadın Hastalıkları ve Doğum Bilgisi, ed. N. Çiçek, C. Akyürek, Ç. Çelik ve A. Haberal, 2. Baskı, 1211-1219, Güneş Kitabevi, 2006. Fa2. L. Önderoğlu, B. S. Karamürsel ve Taşkıran, Ç., “Cesarean”, Jinekolojik ve Obstetrikal Cerrahi, ed. H. Güner, 1549-1581, Güneş Kitabevi, 2005. Fa3. A. Yıldız, ve Taşkıran Ç. “Non-immün hidrops fetalis”. Temel Kadın Hastalıkları ve Doğum Bilgisi. Ed. A. Ayhan, T. Durukan, S. Günalp, T. Gürgan, L. Önderoğlu, K. Yüce. Güneş Kitabevi. Fa4. Taşkıran Ç., ve H. Güner. “Vaginal hysterectomy”. Ürojinekoloji ve pelvik rekonstrüktif cerrahi. Ed. H. Güner. Güneş Kitabevi, 333-342.

Fa5. Taşkıran Ç., ve Ü. Korucuoğlu. Bengin diseases of ovary and tube. Klinikte obstetrik ve jinekoloji. Ed. Nedim Çiçek ve Tamer Mungan. Güneş Kitabevi, 2007. Fa6. Taşkıran, Ç., E. Yılmaz. Upper abdominal cytoreductive surgery. Jinekolojik Cerrahi, ed. H. Güner, Güneş Kitabevi, 2011. Fa7. Taşkıran, Ç., Surgery at early stage endometrial cancer. Jinekolojik Onkoloji, Editör: Ali Ayhan Editör Yardımcıları: Polat Dursun, Murat Gültekin, Çağatay Taşkıran; Güneş Kitabevi, 2013. Fa8. Ercan Yılmaz, Taşkıran, Ç., Endometrial cancer. Temel Kadın Hastalıkları ve Doğum Bilgisi, 3. Baskı, Güneş Kitabevi.

Editorial board membership at book translated from original English version

Danfort’s Obstetrics and Gynecology. Editor: Ali Ayhan Editorial board: Çağatay Taşkıran,

Polat Dursun. Güneş Kitabevi.

b-Chapter in books translated from original English version

Fb1. Rifat Gürsoy, Çağatay Taşkıran. Hormonal status. Bölüm 30. Reproductive Endocrinology. Ed.: Yen & Jaffe. Çeviri Ed.: Serdar Günalp. Güneş Kitabevi, sayfa: 939-964, 2006. Fb2. Çağatay Taşkıran ve Übeyt Akçin. Psychiatric problems. Novak Jinekoloji. 13. Baskı. Çeviri Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 323-351, 2004. Fb3.Rifat Gürsoy, Çağatay Taşkıran. Amenorrhea. Novak Jinekoloji. 13. Baskı. Çeviri Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 843-871, 2004. Fb4. Rifat Gürsoy, Çağatay Taşkıran. Endometriosis. Novak Jinekoloji. 13. Baskı. Çeviri Editörü: Ahmet Erk. Nobel Yayıncılık, sayfa 931-973, 2004. Fb5. Çağatay Taşkıran. Treatment of ascites and intestinal obstruction at terminal patient. Jinekolojik Kanserler-Tartışmalı Konular ve Çözümleriyle. Ed. Prof.Dr.Z.Selçuk Tuncer. Gynecologic Cancer: Controversies in Management, Ed. Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G. Sayfa 727-741, 2004. Fb6. Sezin Yüce, Kunter Yüce, Çağatay Taşkıran. Germ cell, stromal and other tumors. Klinik Jinekolojik Onkoloji, Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, Ed., DıSaıa, Creasman. Sayfa 351-375, 2003. Fb7. Ali Ayhan, Çağatay Taşkıran. Endometrial hyperplasia/Estrogen treatment. Klinik Jinekolojik Onkoloji. Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 113-136, 2003. Fb8. Çağatay Taşkıran. GOG toxicity criteria. Klinik Jinekolojik Onkoloji, (ekler). Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 621-624, 2003. Fb9. Çağatay Taşkıran. Cancer screening. Klinik Jinekolojik Onkoloji, (ekler). Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 633-634, 2003. Fb10. Çağatay Taşkıran. Statistical analysis. Klinik Jinekolojik Onkoloji, (ekler), Ed., Dr. Ali Ayhan. Clinical Gynecologic Oncology, 2002, Ed., DıSaıa, Creasman. Sayfa 629-632, 2003. Fb11. Çağatay Taşkıran. Are endometrial stromal tumors responsive to hormones?HRT ve Kanser. Güneş Kitabevi. Hormone Replacement Therapy and Cancer, Ed., A.R. Genazzani, 148-154, 2003.

Fb12. Çağatay Taşkıran. Breast diseases. Benson&Pernoll Obstetrik ve Jinekoloji El Kitabı, Editör: Prof.Dr. Ali Ayhan, Dr. Gürkan Bozdağ, Palme Yayıncılık, 547-570, 2002. Fb13. Çağatay Taşkıran. Vulvar and vaginal diseases. Benson&Pernoll Obstetrik ve Jinekoloji El Kitabı, Editör: Prof.Dr. Ali Ayhan, Dr. Gürkan Bozdağ, Palme Yayıncılık, 571-598, 2002.

Fb14. Çağatay Taşkıran ve Baran Celtemen. “Malignanat diseases of hematologic and immunologic systems”. High risk pregnancies. Yüksek riskli gebelikler. Ed. Haldun Güner. Güneş Kitabevi, 889-900. d-Certificates.

Fd1. USMLE Step 1, October 1997; ve USMLE Step 2, March 1998.

e-Organization of National Congress or Course

Fe1. Congress secretary. 10. National congress of Gynecologic Oncology. 19-23 Nisan 2006, Antalya. Fe2. Secretary. Video-workshop in gynecologic oncology. 12-14 Şubat 2009, Ankara. Fe3. Course director. Video workshop in gynecologic oncology, precongress course, animal lab. 2011, Ankara.

f-Lectures at National Meetings

Ff1. Targeted therapies in epithelial ovarian cancer. ESGO workshop for epithelial ovarian cancer. 23-24 February 2007, Ankara-TURKEY Ff2. Surgical treatment of uterine carcinosarcomas. Meeting of Turkish Society of Gynecologic Oncology, 9 December 2006, Denizli. Ff3. Screening in cervical cancer., Meeting of Turkish Society of Gynecologic Oncology, 23-24 June 2006, Çanakkale. Ff4. Pregnacy and HPV. Hacettepe University Alumni Meeting. 26-28 May 2006. Ff5. Current treatment of cervical preinvasive diseases. Meeting of Turkish Society of Gynecologic Oncology, 28 January 2006, Hatay. Ff6. Treatment of advanced stage endometrial cancer. Hacettepe University, Gynecologic Oncology Board, invited speaker, 2006.

Ff7. Consolidation treatment and isolated marker relapse at epithelial ovarian cancer. Hacettepe University, CME, 1 April 2006. Ff7. Consolidation treatment for epithelial ovarian cancer. 10. Congress of Turkish Society of Gynecologic Oncology 19-23 April 2006, Antalya. Ff8. The role of neoadjuvant chemotherapy in ovarian cancer. 5. National congress of obstetrics and gynecology 16-21 May 2006. Ff9. Comparison of surgical techniques for vulvar cancer. III. National congress of surgical oncology 9-12 October 2005, Antalya. Ff10. Neoadjuvat chemotherapy for epithelial ovarian cancer. Hacettepe University, Gynecologic Oncology Board, invited speaker, 2005. Ff11. Comparison of LEEP and CKC. III. National congress of surgical oncology, 2003, İstanbul. Ff12. The concept of sentinel lymph node in gynecologic oncology. Current concepts in nuclear medicine. Hacettepe University, CME 11-12 April 2003. Ff13. RIA in Turkey and World. 5. National congress of family planning. 19-22 april, 2007, Ankara. Ff14. Secondary cytoreductive surgery in ovarian cancer. Hacettepe University, Gynecologic Oncology Board, invited speaker, 2007. Ff15. Molecular prognostic factors. 10. Congress of Turkish Society of Gynecologic Oncology, 2008, Antalya. Ff16. Gynecologic pain. 6. National congress of obstetrics and gynecology, 2008, Antalya. Ff17. Laparoscopic hysterectomy. 6. National congress of obstetrics and gynecology, 2008, Antalya. Ff18. Molecular prevention for endometrial cancer. Cancer prevention meeting. 2008, Çeşme. Ff19. Management of urogynecological pain. Family doctors meeting. 9-12 October, 2008, Antalya. Ff20. Total laparoscopic hysterectomy. Video-workshop in gynecologic oncology. 12-14 february 2009, Ankara. Ff21. Colorectal surgery for advanced stage ovarian cancer. Meeting of Turkish Society of Gynecologic Oncology, april 2009, Diyarbakır. Ff22. Management of postoperative pain. 5. National congress of family planning. 23-25 april, 2009, Ankara.

Ff23. Colorectal surgery in epithelial ovarian cancer. 7. National congress of obstetrics and gynecology, 14-19 May, 2009, Girne. Ff24. Treatment for advanced stage cervical cancer. Meeting of Turkish Society of Gynecologic Oncology, Adana, 2010. Ff25. Tumor markers. Meeting of Turkish Society of Gynecologic Oncology, Gaziantep 2010. Ff26. Borderline ovarian tumors? Meeting of Turkish Society of Gynecologic Oncology, Manisa, 2010. Ff27. Surgical staging in local advanced stage cervical cancer. 12. Congress of Turkish Society of Gynecologic Oncology, 2010. Ff28. Resection of bulky lymph nodes. 2. Videoworkshop of Turkish Society of Gynecologic Oncology, 2011. Ff29. Laparoscopic transperitoneal lymphadenectomy. Meeting of Robotic Surgery, İstanbul, 2011. Ff30. Laparoscopic resection of bulky lymph nodes. AAGL-JED meeting, İstanbul, 2011. Ff31. Restaging in epithelial ovarian cancer. 8. National congress of obstetrics and gynecology, Antalya 2011. Ff32. The role of Ca125 in the monitorization of Ovarian Cancer: Pro & Con. Meeting of Turkish-German Association, 2011. Ff33. Surgical treatment of cervical cancer. Meeting of Hacettepe University Oncology Institute, 2011. Ff34. Tips and tricks of laparoscopic hysterectomy. Meeting of TJOD İstanbul, 2012. Ff35. Difficulties of laparoscopic paraaortic dissection. Meeting of Uludag University, Bursa, 2012. Ff36. Laparoscopic management of adnexal mass. JED Workshop, 2012, İstanbul. Ff37. Prevention of complications of laparoscopic hysterectomy. 5. Meeting of Aegian Gynecologic Endoscopy, İzmir, 2012. Ff38. The value of restaging for epithelial ovarian cancer. Meeting of Turkish Society of Gynecologic Oncology, Edirne, 2012. Ff39. Laparoscopic anatomy. Yeditepe University-JED Workshop, 2012. Ff40. Restaging for incompletely treated ovarian cancer patients. 9. National congress of obstetrics and gynecology, Antalya, 2012.

Ff41. LESS Hysterectomy. Developments in minimal invasive surgery III, American Hospital, 2012. Ff42. Laparoscopic myomectomy: Technique, literature, case presentations. Laparoscopy course at Golbasi Laparoscopic Education Center of Gazi University, Ankara 2012. Ff43. Treatment for UPSC and clear cell tumors. 13. Congress of Turkish Society of Gynecologic Oncology, Antalya 2012. Ff44. Step by step resection of pelvic side wall in Wertheim surgery. 13. Congress of Turkish Society of Gynecologic Oncology, Antalya 2012. Ff45. Laparoscopic treatment of early stage epithelial ovarian cancer. 1. MESGE and 5. National JED congress, 2013. Ff46. Laparoscopic anatomy. 4.Gynecologic video-endoscopy and laparoscopic suture course, Istanbul, 2013. Ff47. Laparoscopic treatment of epithelial ovarian cancer, 10. National congress of obstetrics and gynecology, Antalya 2013. Ff48. Laparoscopic pelvic anatomy. Zeynep Kamil Meeting, Istanbul, 2013. f-2-Lectures at International Meetings

Ff2-1. Chairmen, Radiation oncology. 1st World congress on cancer, january 12-14, 2009, India. Ff2-2. The role of cytoreductive surgery in advanced stage epithelial ovarian cancer. 1st World congress on cancer, january 12-14, 2009, India. Ff2-3. Total abdominal colectomy with ileal J-pouch-rectal anastomosis for primary cytoreduction of ovarian cancer. International videoworkshop on radical surgery in gynecologic oncology, Prague, 2010. Ff2-4. Prevention of gynecologic cancer: screening and immunization. NAAMA congress, 2012, İstanbul. Ff2-5. Retroperitoneal Advanced Laparoscopic Surgery for Gynecologic Malignancies and Deep Pelvic Endometriosis. Professor meeting on endoscopic gynecologic surgery, Cleveland, 2013. Ff2-6. Radical Surgery for Deep Infiltrative Endometriosis. 5th International Video Workshop on Radical Surgery in Gynecological Oncology, Prague, 2016.

Ff2-7. Celiac Lymhadenectomy and Liver Resection. 5th International Video Workshop on Radical Surgery in Gynecological Oncology, Prague, 2016. Ff2-8. Advanced Ovarian Cancer: Upper Abdominal and Extended Cytoreduction. 20th International Meeting of the European Society of Gynaecological Oncology in Vienna, Austria, November 4-7, 2017. h-Reviewer

1. International Journal of Gynecological Cancer

2. Gynecologic Oncology

3. Indian Journal of Cancer

4. Journal of Reproductive Medicine

5. European Journal of Obstetrics Gynecology and Reproductive Biology

6. Maturitas

7. Archives of Gynecology and Obstetrics

8. Journal of Surgical Oncology

9. European Journal of Surgical Oncology

10. Annals of Oncology